Hologen and Sysmex establish Saibogen, a joint venture using AI to turn routine blood test data into clinical intelligence
LONDON and KOBE, Japan, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Hologen (HQ: London, UK; CEO: Roland Tegeder), a frontier AI company, and Sysmex Corporation (HQ: Kobe, Japan; President: Iwane Matsui), a global leader in hematology, today announced Saibogen, a blood intelligence company formed as a joint venture between the two…